Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altus Drug Development is a specialty pharmaceutical company based in Laval, Quebec, that focuses on the design and development of Value-Added Medicines (VAMs). The company leverages a suite of proprietary drug delivery platforms, including INTELLITAB for abuse deterrence, FLEXITAB for breakable extended-release tablets, and SmartCelle for micellar delivery of insoluble molecules. Altus specializes in the 505(b)(2) regulatory pathway, repositioning and reformulating known molecules to address unmet medical needs in therapeutic areas such as pain, oncology, and CNS disorders. The company operates as a unique CDMO, providing integrated services from formulation design and pre-clinical testing to clinical batch manufacturing and commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altus Drug Development.